-
Clinicians now have the latest guidance in managing patients who have, or are at risk for, sexually transmitted diseases (STDs) with the just-released 2010 STD Treatment Guidelines.
-
Despite the continued high burden of sexually transmitted infections (STIs) in the United States, an analysis of 2009 national data by the Centers for Disease Control and Prevention (CDC) shows some signs of progress on the prevention front:
-
Results of a new study suggest that nearly one in 10 sexually active teens have same-sex partners, which is almost twice as many as previous research studies have found.
-
Results of a new study indicate fasting glucose and insulin levels remain within normal range for women using injectable or oral contraception, with only slight increases among women using depot medroxyprogesterone acetate (DMPA).
-
Clinician office phones might be ringing following news reports of women in the United Kingdom (UK) who experienced unintended pregnancies while using the contraceptive implant Implanon. How do you counsel women on this form of long-acting contraception?
-
Young women with herpes infections often are treated with the oral antivirals acyclovir, valacyclovir, or famciclovir.
-
The next chart in your inbox is for a healthy 21-year-old nonsmoking woman. She indicates she is interested in using an oral contraceptive (OC) for birth control. What pill do you prescribe?
-
Intraoperative placement of adhesion barriers has been a long-practiced adjuvant to major abdominal/pelvic surgery in an attempt to reduce postoperative complications such as bowel obstruction and infertility.
-
A Single Umbilical Artery (SUA) is found in about 1 in 200 fetuses in the second trimester. Since the finding is associated with an increase in fetal anomalies, it alerts clinicians to search for any of the possible abnormalities linked with this finding.
-
Lewis and colleagues performed an investigator-blinded study of sperm penetrability and quality of mid-cycle cervical mucus between levonorgestrel-releasing intrauterine device (LNG-IUD) users (n = 14) and hormone-free controls (n = 16).